NCT05102799 MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
| NCT ID | NCT05102799 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Limb Girdle Muscular Dystrophy |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-04-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A large cohort of MRI scans from patients with pathogenic variants in the anoctamin 5 gene will be collected through an international collaboration to better describe muscle involvement.
Eligibility Criteria
Inclusion Criteria: * Two pathogenic variants in the anoctamin-5 gene * T1-weighted MR-images of lower back and leg muscles. Exclusion Criteria: \- Concomitant other disorders that also can result in muscular atrophy, i.e. polyneuropathy, other muscle diseases, recent long-term stay in intensive care, among others.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05102799 clinical trial?
This trial is open to participants of all sexes, studying Limb Girdle Muscular Dystrophy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05102799 currently recruiting?
Yes, NCT05102799 is actively recruiting participants. Contact the research team at Nanna.scharff.poulsen@regionh.dk for enrollment information.
Where is the NCT05102799 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT05102799 clinical trial?
NCT05102799 is sponsored by Rigshospitalet, Denmark. The trial plans to enroll 200 participants.